Author： Azmi Asfar S Philip Philip A Zafar Syed F Sarkar Fazlul H Mohammad Ramzi M
Publisher： Informa Healthcare
ISSN： 1472-8222
Source： Expert Opinion on Therapeutic Targets, Vol.14, Iss.6, 2010-06, pp. : 611-620
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Par-4 as a potential target for cancer therapy
By Irby Rosalyn B Kline Christina LB
Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 1, 2013-01 ,pp. :
Access to resources
Recommend
Par-4 for Molecular Therapy of Prostate Cancer
Current Drug Targets, Vol. 4, Iss. 3, 2003-04 ,pp. :
Cytokine Network: New Targeted Therapy for Pancreatic Cancer
Current Pharmaceutical Design, Vol. 18, Iss. 17, 2012-06 ,pp. :
NEDD4: A Promising Target for Cancer Therapy
Current Cancer Drug Targets, Vol. 14, Iss. 6, 2014-07 ,pp. :
Leukotriene A4 Hydrolase as a Target for Cancer Prevention and Therapy
Current Cancer Drug Targets, Vol. 4, Iss. 3, 2004-05 ,pp. :